Cepheid launches next-generation Xpert Flu diagnostic test

28 October 2013

Cepheid has launched its next generation Xpert Flu test for the GeneXpert System, offering on-demand STAT testing for triage, outbreaks, emergencies and high risk patient management.

The molecular diagnostic test, which has received the CE IVD mark, is capable of providing on-demand results in just over an hour. With faster turnaround times for improved workflows, plus wider coverage, it enables real-time determination of Flu A and Flu B infection, as well as the identification of 2009 H1N1, maximising medical decision making. This leads to improved isolation and infection control measures, enhancing patient flow and bed use, and reducing the pressure on hospital resources.

Xpert Flu is a key component of Cepheid’s Winter Care Bundle, comprising of the Xpert Flu, Xpert SA Nasal Complete, Xpert C. difficile and Xpert Norovirus rapid tests, which are aimed at helping hospitals manage highly transmissible infections and reduce the potential for preventable ward closures.


To top